655 (Glyburide and Metformin Hydrochloride 5 mg / 500 mg)
Pill with imprint 655 is Yellow, Capsule-shape and has been identified as Glyburide and Metformin Hydrochloride 5 mg / 500 mg. It is supplied by Cadila Healthcare Limited.
Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 655
Glyburide and Metformin Hydrochloride
- Imprint
- 655
- Strength
- 5 mg / 500 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 65841-0826
- Inactive Ingredients
-
calcium carbonate,
microcrystalline cellulose,
croscarmellose sodium,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
hypromellose 2910 (15 mPa.s),
lactose monohydrate,
magnesium stearate,
polyethylene glycol 4000,
povidone k30,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "655"
More about glyburide / metformin
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (5)
- Drug images
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.